Exelixis
EXEL
#1324
Rank
$16.97 B
Marketcap
$69.57
Share price
1.25%
Change (1 day)
68.00%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company